INTOXICATION OF HIGH-AFFINITY IL-2 RECEPTOR POSITIVE THYMOCYTES BLOCKS EARLY STAGES OF T-CELL MATURATION

被引:5
|
作者
MASLINSKI, W
MURPHY, JR
STROM, TB
机构
[1] BETH ISRAEL HOSP, DEPT MED, 330 BROOKLINE AVE, BOSTON, MA 02215 USA
[2] HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA
关键词
CYTOKINES; DIPHTHERIA TOXIN FUSION PROTEIN; INTERLEUKINS; T-CELL DEVELOPMENT;
D O I
10.1093/intimm/4.4.509
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Early murine fetal thymocytes express functional, high affinity IL-2 receptors as determined by: (i) the presence of IL-2R beta-chain (p75) mRNA; (ii) IL-2 (10 U/ml) induced cell proliferation/cellular maturation in lobe submersion cultures (LSC). Under the influence of IL-2, early thymocytes differentiate in vitro into more mature, early single positive CD4-CD8+ followed in vivo by double Positive CD4+CD8+ and single positive CD4+CD8-T and CD4-CD8+ thymocytes. Specific intoxication of high affinity IL-2R Positive thymocytes by recombinant interleukin-2-diphtheria toxin-related fusion protein (DAB486-IL-2) results in transient, dose dependent blockade of in vivo and in vitro thymocyte maturation. DAB486-IL-2 induced effects upon in vivo maturation are reversible within 2 weeks after cessation of drug administration. Taken together, these results demonstrate the expression of functional, high affinity IL-2 receptors on early thymocytes. Elimination of high affinity IL-2 receptor positive thymocytes with DAB486-IL-2 results in transient blockade of T cell maturation. Since DAB486-IL-2 is now in clinical trial, it is reassuring to note that it does not permanently disrupt thymic maturation.
引用
收藏
页码:509 / 517
页数:9
相关论文
共 50 条
  • [41] INHIBITORS OF IL-2 PRODUCTION AND IL-2 RECEPTOR EXPRESSION IN HUMAN-LEUKEMIC T-CELL LINE, JURKAT
    KOIZUMI, T
    NAKAO, Y
    MATSUI, T
    KATAKAMI, Y
    KATAKAMI, N
    FUJITA, T
    CELLULAR IMMUNOLOGY, 1986, 103 (02) : 469 - 475
  • [42] NEURO-ENDOCRINE MODULATION OF T-CELL IL-2 RECEPTOR EXPRESSION
    KILROY, TE
    KLEINHENZ, ME
    CLINICAL RESEARCH, 1985, 33 (02): : A309 - A309
  • [43] NUCLEAR LOCATION OF THE MOUSE IL-2 RECEPTOR DURING T-CELL ACTIVATION
    JOTHY, S
    ABADIE, A
    FRAUSSARD, P
    DUPHOT, M
    THEZE, J
    FASEB JOURNAL, 1988, 2 (06): : A1655 - A1655
  • [44] TRANSIENT NUCLEAR LOCATION OF THE IL-2 RECEPTOR DURING T-CELL ACTIVATION
    JOTHY, S
    ABADIE, A
    FROUSSARD, P
    DUPHOT, M
    THEZE, J
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1989, 50 (01) : 84 - 91
  • [45] UP-REGULATION BY INTERLEUKIN-2 (IL-2) AND INTERLEUKIN-1 (IL-1) OF HIGH AND LOW AFFINITY IL-2 RECEPTORS ON A T-CELL HYBRIDOMA
    ERARD, F
    CORTHESY, P
    COMBE, MC
    NABHOLZ, M
    EXPERIENTIA, 1985, 41 (06): : 781 - 781
  • [46] Soluble, High-Affinity T-cell Receptors as Cancer Therapeutics
    Ashfield, Rebecca
    Adams, Katherine
    Bossi, Giovanna
    Williams, Daniel
    Dennis, Rebecca
    Paston, Samantha
    Harper, Jane
    Hassan, Namir
    McCormack, Emmet
    Iakobsen, Bent
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (09) : 1002 - 1002
  • [47] INDUCTION OF IL-2 RECEPTORS BUT LACK OF IL-2 RESPONSIVENESS IN T-CELL MALIGNANCIES
    DEBATIN, KM
    WOODROOFE, L
    FISCHER, J
    LAHM, H
    FALK, W
    KRAMMER, PH
    IMMUNOBIOLOGY, 1987, 175 (04) : 287 - 287
  • [48] LACK OF IL-2 DEPENDENT PROLIFERATION DESPITE SIGNIFICANT EXPRESSION OF HIGH-AFFINITY IL-2 RECEPTOR ON MURINE LYMPHOCYTE-T CLONES LATE AFTER ANTIGENIC-STIMULATION
    CHURILLA, AM
    BRACIALE, VL
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 292 - 292
  • [49] Intrabody-mediated knockout of the high-affinity IL-2 receptor in primary human T cells using a bicistronic lentivirus vector
    JH Richardson
    W Hofmann
    JG Sodroski
    WA Marasco
    Gene Therapy, 1998, 5 : 635 - 644
  • [50] DIFFERENCES IN IL-2 RECEPTOR LEVELS BETWEEN MYCOSIS-FUNGOIDES AND CUTANEOUS TYPE ADULT T-CELL LEUKEMIA/LYMPHOMA IN THE EARLY STAGES OF THE DISEASE
    OISHI, M
    JOHNO, M
    ONO, T
    HONDA, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (05) : 710 - 715